Induction chemotherapy for patients with Locally advanced triple negative breast cancer.

被引：0
|
作者：
Ignatova, Ekaterina [1 ]
Frolova, Mona [1 ]
Stenina, Marina B. [1 ]
Petrovsky, Alexander [1 ]
Tjulandin, Sergei [1 ]
机构：
[1] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e12573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12573
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
    Cortes, J.
    Rugo, H. S.
    Cescon, D. W.
    Im, S-A
    Yusof, M. M.
    Gallardo, C.
    Lipatov, O.
    Barrios, C. H.
    Perez-Garcia, J.
    Iwata, H.
    Masuda, N.
    Otero, M. Torregroza
    Gokmen, E.
    Loi, S.
    Guo, Z.
    Zhou, X.
    Karantza, V
    Pan, W.
    Schmid, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (03): : 217 - 226
  • [32] Chemotherapy in locally advanced or metastatic colonic cancer.
    Ducreux, M
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (3BIS): : S191 - S200
  • [33] Barriers to Treatment in Patients with Locally Advanced and Inflammatory Breast Cancer.
    Bourdeanu, L.
    Luu, T.
    Chung, C. T.
    Mortimer, J.
    Hurria, A.
    Baker, N.
    Swain-Cabriales, S.
    Helton, S.
    Smith, D.
    Somlo, G.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 673S - 674S
  • [34] Phase II trial of neoadjuvant chemotherapy with carboplatin and nab-paclitaxel in patients with triple negative locally advanced and inflammatory breast cancer
    Somlo, G.
    Chung, S.
    Frankel, P.
    Hurria, A.
    Koehler, S.
    Kruper, L.
    Mortimer, J. E.
    Paz, B.
    Robinson, K.
    Taylor, L.
    Vito, C.
    Waisman, J.
    Yeon, C.
    Yim, J.
    Yuan, Y.
    Tong, T.
    [J]. CANCER RESEARCH, 2016, 76
  • [35] NEOADJUVANT PLATINUM CONTAINING REGIMEN FOR LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER
    Rahal, M. M.
    Ramadan, H.
    Hassan, E.
    Arini, A.
    Mosleh, H.
    Al Naimy, N.
    Senan, E.
    Abdelwarith, A.
    Al Faraj, A.
    Halawani, H.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 114 - 115
  • [36] ROLE OF CISPLATIN AND DOXORUBICIN AS NEOADJUVANT IN LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER
    Athar, Azka
    [J]. BREAST, 2018, 41 : S21 - S21
  • [37] Phase I/II trial of pembrolizumab in combination with binimetinib in unresectable locally advanced or metastatic triple negative breast cancer.
    Chumsri, Saranya
    Polley, Mei-Yin
    Anderson, Sarah L.
    O'Sullivan, Ciara Catherine Maria
    Colon-Otero, Gerardo
    Knutson, Keith L.
    Thompson, E. Aubrey
    Moreno-Aspitia, Alvaro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [38] Impact of Induction Chemotherapy in Locally Advanced HPV-negative Oropharyngeal Cancer. A Propensity Score-matched analysis
    De Felice, Francesca
    Abate, Gessica
    Galdieri, Alessandro
    Bulzonetti, Nadia
    Musio, Daniela
    Tombolini, Vincenzo
    [J]. ANTICANCER RESEARCH, 2016, 36 (12) : 6667 - 6672
  • [39] Breast conservation following induction chemotherapy for locally advanced breast cancer: A personal experience
    Schwartz, GF
    [J]. BREAST JOURNAL, VOL 2, NO 1, JANUARY/FEBRUARY 1996: FIRST ANNUAL MULTIDISCIPLINARY SYMPOSIUM ON BREAST DISEASE, 1996, : 78 - 82
  • [40] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
    Abe, E.
    Hayashi, N.
    Yoshida, A.
    Hamaoka, T.
    Yagata, H.
    Tsugawa, K.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Nakamura, S.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
12345